NCT07294703 Factors Associated With Breast Cancer Risks and Outcomes
| NCT ID | NCT07294703 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Memorial Sloan Kettering Cancer Center |
| Condition | Breast Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 750 participants |
| Start Date | 2025-12-08 |
| Primary Completion | 2031-12-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 750 participants in total. It began in 2025-12-08 with a primary completion date of 2031-12-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to learn more about risks and outcomes of breast cancer in people with different backgrounds. Tissue and blood will be collected from participants for research purposes. Participants will complete questionnaires during their standard medical care. The study will not provide treatment for cancer or any other condition.
Eligibility Criteria
Women 18 years and older who are patients with a suspicious breast finding who present to breast radiology at MSK for biopsy or any new breast cancer patient seen at MSK undergoing surgery. Inclusion Criteria: A patient cannot be considered eligible for this study unless the following conditions are met. * Patients with a suspicious breast finding who present to breast radiology at MSK for biopsy or any new breast cancer patient who is a surgical candidate seen at MSK. * Women 18 years of age and older are eligible to participate in the study. Exclusion Criteria: * Patients presenting with a suspicious breast mass or breast cancer less than 1 cm. * Patients presenting to clinic with only microinvasion * Patients who are less than 18 years of age * Patients unable to complete the survey, including IDMC patients.
Contact & Investigator
Neha Goel, MD, MPH
PRINCIPAL INVESTIGATOR
Memorial Sloan Kettering Cancer Center
Frequently Asked Questions
Who can join the NCT07294703 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Breast Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07294703 currently recruiting?
Yes, NCT07294703 is actively recruiting participants. Contact the research team at goeln1@mskcc.org for enrollment information.
Where is the NCT07294703 trial being conducted?
This trial is being conducted at Basking Ridge, United States, Middletown, United States, Montvale, United States, Commack, United States and 3 additional locations.
Who is sponsoring the NCT07294703 clinical trial?
NCT07294703 is sponsored by Memorial Sloan Kettering Cancer Center. The principal investigator is Neha Goel, MD, MPH at Memorial Sloan Kettering Cancer Center. The trial plans to enroll 750 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.